Clinical Trial Update: Study Evaluating the Safety and Tolerability of L-377202 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety and tolerability of L-377202 in hormone refractory and standard prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-refractory Prostate Cancer
• Prostate Cancer

Drugs mentioned

• L-377202

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Hormone Refractory Prostate Cancer, Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED